Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v7-FR
Language French French
Date Updated 2018-02-27 2018-02-27
Drug Identification Number 02246414 02246414
Brand name AVELOX I.V. AVELOX I.V.
Common or Proper name moxifloxacin injection moxifloxacin injection
Company Name BAYER INC BAYER INC
Ingredients MOXIFLOXACIN MOXIFLOXACIN
Strength(s) 400MG 400MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 250 mL Ready-to-use minibag 250 mL Ready-to-use minibag
ATC code J01MA J01MA
ATC description QUINOLONE ANTIBACTERIALS QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-06-30 2017-06-30
Actual start date
Estimated end date 2018-03-29 2018-03-29
Actual end date 2018-02-23 2018-02-23
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Avelox I.V. is now in bottle and available to the market. Avelox I.V. is now in bottle and available to the market.
Health Canada comments